23rd Jan 2008 07:01
Ascribe plc23 January 2008 Press Release 23 January 2008 Ascribe plc ("Ascribe" or "the Group") Trading Update Ascribe plc (AIM:ASP), the International Health IT company, is pleased toprovide an update on current trading in advance of its interim results for thesix months ended 31 December 2007, to be announced on 12 March 2008. The Groupconfirms that it is on track to meet market expectations for the full year. The Group's order book of new sales has grown to a record level of £3.3M,following a series of significant sales wins in December 2007 which includes amajor integrated order. The Board believes that increased demand in Decemberindicates the market as a whole is shifting to local level decision making. TheBoard therefore expects the second half of the financial year to be strong asthe growing order book is delivered. Commenting on recent trading, Stephen Critchlow, CEO of Ascribe said: "I amdelighted with the progress the Group has made in the first half of ourfinancial year. Ascribe has a reputation for delivering robust technology whichis critically focused on the needs of clinicians and their patients at the pointof care. The strength of our order book stems from the ever-increasing autonomyof local purchasers within the NHS to make healthcare IT decisions." - End - For further information please contact:Ascribe plcStephen Critchlow, Executive Chairman Tel: : +44 (0) 870 053 [email protected] www.ascribe.comJeremy Lee, Finance Director Tel: : +44 (0) 870 053 [email protected] www.ascribe.com Investment enquiries:CenkosIan Soanes Tel: +44 (0) 20 7397 [email protected] www.cenkos.com Media enquiries:AbchurchStephanie Cuthbert / Justin Heath Tel: +44 (0) 20 7398 [email protected] www.abchurch-group.com Notes to Editors Ascribe plc is a leading healthcare company that develops and markets softwaresolutions supporting patient, clinical and business processes to Primary &Secondary healthcare providers in the UK and overseas. Ascribe is committed to providing technologies that improve patient safetystandards and the company's solutions directly improve patient care and deliverfinancial savings to customers. The Group sells directly to hospitals andPrimary Care Trusts. Ascribe's technology enables customers to report morethoroughly on patient care and also benefits patients by seamlessly contributingto their electronic health care record. The Group provides solutions to clinical professionals in all healthcaresectors; customers include Emergency and Minor Injuries Units, Mental Health andSocial Care Units, Hospitals requiring patient administration systems (PAS) andmedical equipment management, Hospital and Retail Pharmacies, and GeneralPractice surgeries. Offering patient and decision support information to theseclinicians in context with their activity is the key to the company's ongoingsuccess. Ascribe plc was floated on AIM in 2004, and currently employs over 220 personnelthrough its operating companies in the UK, Kenya, Australia and New Zealand. Formore information, please visit www.ascribe.com (c) Ascribe 2008. Ascribe is a registered trademark of Ascribe plc. All otherbrands and product names and trademarks are the registered property of theirrespective companies. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
ASP.L